FDA sued for failing to act on painkiller

A consumer group has sued the FDA, saying the agency has been too slow in acting against the painkiller known as Darvon, a.k.a. propoxyphene. In its suit, Public Citizen says FDA broke the law by not ruling on its petition against drug, which it filed two years ago. The agency was required to act on it within six months, the suit says. Report

Suggested Articles

The Trump administration has selected five COVID-19 vaccines for Operation Warp Speed, the NYT reports, with Big Pharma dominating the list.

Racing with some COVID-19 vaccine heavyweights, Novavax has brought on a partner to manufacture adjuvant for its in-development shot. 

Bristol Myers Squibb's Zeposia will leverage promising top-line phase 3 data into a possible FDA approval in the lucrative ulcerative colitis market.